MarketCap
Facebook
X
TelegramCountry |
 Britain |
IPO year |
2013 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
- |
Market Cap[1] |
$ 562 M |
EBITDA (LTM) |
$ 15 K |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE |  USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 204.3 | 0.23 % | $ 22.7 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 89.2 | -0.32 % | $ 4.17 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Co-Diagnostics
CODX
|
$ 4.56 | -2.98 % | $ 6.07 M | Nasdaq Capital Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 18.61 | -0.91 % | $ 573 M | Nasdaq Global Market | USA |
 |
Castle Biosciences
CSTL
|
$ 20.7 | -1.48 % | $ 600 M | Nasdaq Global Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 161.44 | -2.87 % | $ 25 B | Nasdaq Global Select Market,SPB | USA |
 |
Guardant Health
GH
|
$ 131.25 | 0.26 % | $ 16.5 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 23.17 | -2.06 % | $ 1.23 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
ICON Public Limited Company
ICLR
|
$ 145.78 | -2.76 % | $ 11.4 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Interpace Biosciences
IDXG
|
$ 1.6 | -3.03 % | $ 7.08 M | Nasdaq Global Select Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 104.25 | -0.07 % | $ 7.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 188.43 | 0.45 % | $ 9.34 B | NYSE,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.33 | -1.85 % | $ 399 M | Nasdaq Global Select Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 468.79 | -1.32 % | $ 13.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 130.24 | -0.96 % | $ 23.3 B | NYSE,SPB |  Schweiz |
 |
NeoGenomics
NEO
|
$ 11.15 | -2.79 % | $ 1.43 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.38 | -5.51 % | $ 406 M | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 19.11 | 1.7 % | $ 428 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 212.9 | -2.89 % | $ 29.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 9.45 | 0.32 % | $ 843 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.39 | 1.05 % | $ 25 B | NYSE |  Niderland |
 |
Senseonics Holdings
SENS
|
$ 7.37 | 0.55 % | $ 308 M | NYSE American | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 77.61 | 4.8 % | $ 4.64 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.06 | -1.56 % | $ 4.73 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 264.76 | -0.19 % | $ 22 B | NYSE,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 469.88 | -1.22 % | $ 177 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.66 | -2.22 % | $ 237 M | Nasdaq Global Select Market | Irlanda |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Neogen Corporation
NEOG
|
$ 9.23 | -0.16 % | $ 2 B | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.